Æ»¹ûÒùÔº

Updated: Sun, 10/06/2024 - 10:30

From Saturday, Oct. 5 through Monday, Oct. 7, the Downtown and Macdonald Campuses will be open only to Æ»¹ûÒùÔº students, employees and essential visitors. Many classes will be held online. Remote work required where possible. See Campus Public Safety website for details.


Du samedi 5 octobre au lundi 7 octobre, le campus du centre-ville et le campus Macdonald ne seront accessibles qu’aux étudiants et aux membres du personnel de l’Université Æ»¹ûÒùÔº, ainsi qu’aux visiteurs essentiels. De nombreux cours auront lieu en ligne. Le personnel devra travailler à distance, si possible. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

George Zogopoulos

Academic title(s): 

Associate Professor of Surgery and Oncology

George Zogopoulos
Contact Information
Address: 

Goodman Cancer Institute
1160 Pine Avenue West
Montreal, Quebec H3A 1A3
Lab: Room 611

Office: Æ»¹ûÒùÔº Health Centre, 
EM2.3210, 1001Decarie Blvd.,
Montreal, Quebec, H4A 3J1

Email address: 
george.zogopoulos [at] mcgill.ca
Phone: 
514-934-1934, ext. 36306
Department: 
Goodman Cancer Institute
Area(s): 
Cancer
Genetics
Current research: 

Dr. Zogopoulos’ lab studies the genetics and oncogenomics of pancreaticobiliary cancers. His research includes discovery of genetic associations with familial pancreatic cancer, and therapeutic opportunities for pancreaticobiliary cancers driven by homologous recombination deficiency.

To pursue his research interests, Dr. Zogopoulos established and directs the Quebec Pancreas Cancer Study (QPCS), a familial patient registry and biospecimen repository for pancreatic, biliary tract and peri-ampullary malignancies. His program’s resources also include patient-derived tumour xenograft and cell-line libraries.

His translational research program is integrated into the ambulatory oncology clinics at the Æ»¹ûÒùÔº Health Centre to facilitate access to genetic counseling and testing as well as precision oncology and early detection opportunities for patients with pancreaticobiliary cancers.

Dr. Zogopoulos is the Pancreatic Disease Oriented Group co-Chair of the Canadian Cancer Trials Group (CCTG), and his research activities also include the pan-Canadian Pancreatic Cancer Profiling for Individualized Care (EPPIC) study, the Quebec Consortium for Novel Cancer Therapeutics and Biomarkers, the Pancreatic Cancer Genetic Epidemiology (PACGENE) consortium, and the Pancreatic Cancer Early Detection (PRECEDE) consortium.

His clinical practice focuses on the surgical treatment of pancreatic, biliary and hepatic malignancies, as well as abdominal organ transplantation with a focus on transplant oncology. 

Selected publications: 

Back to top